Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
23/01/2024 06:05
Jan 23 (Reuters) - Biosenic SA BIOS.BR :
* BIOSENIC FILES FOR ADDITIONAL PATENT PROTECTION FOLLOWING
NEW
CLINICAL EVIDENCE OF EFFICACY FOR JTA-004 IN OSTEOARTHRITIS
* ANALYSIS DETECTED PAIN-RELIEVING EFFICACY SUPERIOR TO BOTH
PLACEBO AND ACTIVE COMPARATOR
* BIOSENIC NOW INTENDS TO EXPAND PATENT PROTECTION FOR
"HYALURONIC
ACID-BASED COMPOSITIONS AND RELATED METHODS FOR USE IN TREATMENT
OF OSTEOARTHRITIS IN SPECIFICALLY SELECTED SUBJECTS"
Source text for Eikon: urn:newsml:reuters.com:*:nGNEVbcTz
Further company coverage: BIOS.BR
(Gdansk Newsroom)
((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd